• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
NVP-LDE225 Diphosphate

NVP-LDE225 Diphosphate

Product ID N8663
Cas No. 1218778-77-8
Purity ≥98%
Product Unit SizeCostQuantityStock
1 mg $52.50 In stock
5 mg $78.80 In stock
10 mg $94.50 In stock
25 mg $131.30 In stock
50 mg $210.00 In stock
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

NVP-LDE225 (Sonidegib Diphosphate) is an inhibitor of Smo that prevents hedgehog (Hh) signaling; it exhibits anticancer chemotherapeutic and anti-metastatic activities. NVP-LDE225 is currently approved for the treatment of basal cell carcinoma but is also in clinical trials as a potential treatment for other cancers. In renal cell carcinoma cells, NVP-LDE225 inhibits cellular proliferation, migration, and invasion; in animal models, it increases survival rates and decreases tumor growth. NVP-LDE225 also inhibits cell viability in prostate cancer cells. In animal models of prostate cancer, this compound inhibits the epithelial-to-mesenchymal transition (EMT), induces apoptosis, decreases the expression of Bcl-2, Bcl-xl, XIAP, and survivin, and increases the expression of Bax and Bak; it also inhibits tumor growth. Smo antagonists such as NVP-LDE225 also cause alopecia, likely due to alteration in hair follicle embryology.

Product Info

Cas No.

1218778-77-8

Purity

≥98%

Formula

C26H26F3N3O3 • 2H3PO4

Formula Wt.

681.49

IUPAC Name

N-{6-[(2R,6S)-2,6-Dimethyl-4-morpholinyl]-3-pyridinyl}-2-methyl-4'-(trifluoromethoxy)-3-biphenylcarboxamide phosphate (1:2)

Synonym

Erismodegib, Sonidegib Diphosphate, LDE225, LDE 225, NVP-LDE-225, NVP LDE225

Solubility

10 mM in DMSO

Appearance

White Crystal Powder

Shipping and Storage

Store Temp

-20°C

Ship Temp

Ambient

Downloads

MSDS

N8663 MSDS PDF

Info Sheet

N8663 Info Sheet PDF

References

Ferguson J, Hannam S, Toholka R, et al. Hair Loss and Hedgehog Inhibitors - A Class Effect? Br J Dermatol. 2014 Dec 18. [Epub ahead of print]. PMID: 25523648.

D'Amato C, Rosa R, Marciano R, et al. Inhibition of Hedgehog signalling by NVP-LDE225 (Erismodegib) interferes with growth and invasion of human renal cell carcinoma cells. Br J Cancer. 2014 Sep 9;111(6):1168-79. PMID: 25093491.

Nanta R, Kumar D, Meeker D, et al. NVP-LDE-225 (Erismodegib) inhibits epithelial-mesenchymal transition and human prostate cancer stem cell growth in NOD/SCID IL2Rγ null mice by regulating Bmi-1 and microRNA-128. Oncogenesis. 2013 Apr 8;2:e42. PMID: 23567619.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • G720004

    GS-4997

    ASK1 inhibitor.

    ≥99%
  • H9861

    Hypericin

    Naphthodianthrone found in Hypericum; dopamine ...

    ≥98%
  • M1749

    Memantine Hydrochloride

    D2 agonist, NMDA, 5-HT3, α7 nAChR antagonist.<...

    ≥97%
  • L0108

    Lacidipine

    Calcium channel blocker.

    ≥98%
  • F4532

    Flibanserin

    5-HT1A agonist, 5-HT2A antagonist.

    ≥97%
  • C9612

    Cyclosporin C

    Cyclosporin metabolite; weak calmodulin inhibit...

    ≥98%
  • C324091

    Ciclesonide

    Corticosteroid

    ≥98%
  • C1627

    Cefaclor Monohydrate

    β-lactam cephalosporin; penicillin binding pro...

    ≥97%
  • M324083

    Micafungin

    Echinocandin

    ≥95%
  • A5044

    Amlodipine Besylate

    Dihydropyridine, FIASMA; L-type Ca2+ channel bl...

    ≥98%
  • F4481

    Flurbiprofen

    NSAID; COX-1/2 inhibitor.

    ≥98%
  • P3463

    Piperacillin Sodium

    β-lactam; penicillin binding protein inhibitor...

    ≥95%
  • C4658

    Clopidogrel Sulfate

    Thienopyridine; P2Y12 antagonist.

    ≥98%
  • G0250

    cGAMP Disodium [STING Ligand]

    Cyclic dinucleotide that detects cytosolic DNA ...

    ≥98%
  • E2258

    Efonidipine Hydrochloride

    Calcium channel blocker.

    ≥98%
  • F3205

    Fibrinogen γ-chain Dodecapeptide

    Platelet substitute, peptide; GP IIb/IIIa activ...

    ≥95%
  • I7341

    Isoniazid

    Nicotinic acid derivative; InhA inhibitor.

    ≥98%
  • T4800

    TM3-0089 Sodium Monohydrate

    CRTH2 inhibitor.

    ≥98%
  • P3600

    PJ34 Hydrochloride

    PARP inhibitor; potential Pim1 inhibitor.

    ≥95%
  • F4782

    Fludarabine Phosphate

    Nucleoside (adenosine) analog; DNA chain termin...

    ≥98%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2025 LKT Laboratories, All Rights Reserved - Products for research use only